Boehringer Ingelheim has started a proof-of-concept trial of a drug that could offer the first oral treatment for geographic atrophy (GA), a major cause of irreversible sight loss that affects ...

Astellas confirmed today that it will withdraw its EMA filing for avacincaptad pegol as a treatment for eye disorder geographic atrophy (GA), based on feedback from the EU regulator. It is a major ...

Syfovre, also known as pegcetacoplan, is a medicine used to treat geographic atrophy, which is the advanced form of dry age-related macular degeneration. Geographic atrophy can cause irreversible ...

Hereditary optic neuropathies are a prominent cause of blindness in both children and adults. The disorders in this group share many overlapping clinical characteristics, including morphological ...

The subscapularis is a muscle in your shoulder. If this muscle tears you may experience shoulder pain, shoulder or arm weakness, and “clicking” in your shoulder when you rotate your arm. Some possible ...

Not every question in the management of patients with GA has a clear answer—the two retina specialists work through the ones clinicians face most often in practice. Garg opens with a question he still ...

The Division of Autonomic Disorders, in conjunction with NYU Langone’s Dysautonomia Center, leads a comprehensive clinical research program dedicated to multiple system atrophy (MSA). As a world-class ...

Aims To investigate the progression pattern of diffuse chorioretinal atrophy (DCA) among Chinese participants with high myopia. Methods This is a longitudinal, non-interventional study. Participants ...

FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease ...